- Home
- WRLD vs SANA Comparison
WRLD vs SANA Comparison
Compare WRLD & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRLD
- SANA
- Stock Information
- Founded
- WRLD 1962
- SANA 2018
- Country
- WRLD United States
- SANA United States
- Employees
- WRLD N/A
- SANA N/A
- Industry
- WRLD Finance: Consumer Services
- SANA Medicinal Chemicals and Botanical Products
- Sector
- WRLD Finance
- SANA Health Care
- Exchange
- WRLD Nasdaq
- SANA Nasdaq
- Market Cap
- WRLD 859.5M
- SANA 983.4M
- IPO Year
- WRLD 1991
- SANA 2021
- Fundamental
- Price
- WRLD $179.27
- SANA $4.45
- Analyst Decision
- WRLD
- SANA Strong Buy
- Analyst Count
- WRLD 0
- SANA 6
- Target Price
- WRLD N/A
- SANA $8.00
- AVG Volume (30 Days)
- WRLD 60.9K
- SANA 3.8M
- Earning Date
- WRLD 10-28-2025
- SANA 11-07-2025
- Dividend Yield
- WRLD N/A
- SANA N/A
- EPS Growth
- WRLD 10.95
- SANA N/A
- EPS
- WRLD 14.92
- SANA N/A
- Revenue
- WRLD $567,706,032.00
- SANA N/A
- Revenue This Year
- WRLD N/A
- SANA N/A
- Revenue Next Year
- WRLD $3.55
- SANA N/A
- P/E Ratio
- WRLD $12.02
- SANA N/A
- Revenue Growth
- WRLD 0.80
- SANA N/A
- 52 Week Low
- WRLD $104.99
- SANA $1.26
- 52 Week High
- WRLD $185.48
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- WRLD 54.91
- SANA 69.58
- Support Level
- WRLD $174.59
- SANA $4.10
- Resistance Level
- WRLD $185.39
- SANA $4.82
- Average True Range (ATR)
- WRLD 7.18
- SANA 0.29
- MACD
- WRLD -0.45
- SANA 0.08
- Stochastic Oscillator
- WRLD 66.10
- SANA 80.19
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.